Literature DB >> 22906579

Severe tracheomalacia in the ICU: identification of diagnostic criteria and risk factor analysis from a case control study.

Chitra Kandaswamy1, Garrett Bird, Narinder Gill, Edward Math, Jose Joseph Vempilly.   

Abstract

BACKGROUND: Severe tracheomalacia (STM) is being increasingly recognized as a cause for respiratory failure in the ICU. The diagnosis is often overlooked, as chest radiography appears normal, and the role of invasive diagnostic testing for this diagnosis is not well described in the ICU setting. The prevalence and risk factors for STM are not known, and computed tomography (CT) based diagnostic criteria for ventilated patients are not well studied.
METHODS: Patients admitted between January 2008 and December 2010, with respiratory failure and who failed ventilator discontinuation or required reintubation, were screened for the presence of any tracheal collapse, utilizing prior CT of the chest. Bronchoscopically confirmed cases were compared with age and sex matched controls to identify risk factors.
RESULTS: Twenty-five subjects were identified as having STM, which represented 0.7% of ICU admissions and 1.6% of subjects with respiratory failure. The mean ICU stay was significantly longer in STM (30 d, 95% CI 19.7-40 d), compared to controls (4.4 d, 95% CI 3.6-5.2 d). Obesity (odds ratio 1.26, 95% CI 1.04-1.54) and gastro-esophageal reflux (odds ratio 31, 1.7- 586) were associated with increased risk for STM. The pre-intubation PaCO2 (68 mm Hg, 95% CI 57-79 mm Hg) was significantly higher in STM, compared to controls (38 mm Hg, 95% CI 35-41). The distal tracheal antero-posterior diameter (2.80 mm, 95% CI 2.15-3.46) was significantly lower in STM. A receiver operating characteristic analysis showed a distal tracheal antero-posterior diameter < 7 mm to be the optimal cutoff measurement to diagnose STM.
CONCLUSION: STM was associated with prolonged ICU stay. A distal tracheal antero-posterior diameter < 7 mm on a non-intubated CT chest was suggestive of STM that required a confirmatory bronchoscopy. Gastroesophageal reflux disease and obesity were potential risk factors.
© 2013 Daedalus Enterprises.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22906579     DOI: 10.4187/respcare.01866

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  7 in total

1.  Potential role of the airway wall in the asthma of obesity.

Authors:  Jason H T Bates; Anne E Dixon
Journal:  J Appl Physiol (1985)       Date:  2014-10-23

2.  Tracheobronchomalacia in a patient on invasive mechanical ventilation: the role of electrical impedance tomography in its detection and positive end-expiratory pressure titration.

Authors:  Olívia Meira Dias; Eduardo Leite Vieira Costa; Daniel Antunes Silva Pereira; Caroline Nappi Chaves; Samia Zahi Rached; Carmen Silvia Valente Barbas
Journal:  J Bras Pneumol       Date:  2015 Mar-Apr       Impact factor: 2.624

3.  Excessive Dynamic Airway Collapse: An Unexpected Contributor to Respiratory Failure in a Surgical Patient.

Authors:  Michael R Lyaker; Victor R Davila; Thomas J Papadimos
Journal:  Case Rep Anesthesiol       Date:  2015-06-08

4.  Laser tracheobronchoplasty: a novel technique for the treatment of symptomatic tracheobronchomalacia.

Authors:  Paul Castellanos; Manjunath Mk; Ihab Atallah
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-20       Impact factor: 2.503

5.  Refractory asthma treatment is complicated by tracheobronchomalacia: case reports and review of the literature.

Authors:  Sawad Boonpiyathad; Atik Sangasapaviliya
Journal:  Case Rep Med       Date:  2013-05-13

6.  Lung mesenchymal expression of Sox9 plays a critical role in tracheal development.

Authors:  Gianluca Turcatel; Nicole Rubin; Douglas B Menke; Gary Martin; Wei Shi; David Warburton
Journal:  BMC Biol       Date:  2013-11-25       Impact factor: 7.431

7.  Post-intubation tracheobronchomalacia in a young adult: A rare case report.

Authors:  Yuttiwat Vorakunthada; Weerapong Lilitwat
Journal:  Respir Med Case Rep       Date:  2017-12-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.